TrialAntimicrobial agents and chemotherapy2009

Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy.

Joseph J Eron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.